Related Experiment Video
Updated: Jun 5, 2026
05:23
Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
[Helicobacter pylori--friend or foe?]
Irina Ciortescu1, Mărioara Stan
1Universitatea de Medicină şi Farmacie Gr.T. Popa Iaşi, Facultatea de Medicină.
Summary
Helicobacter pylori (H. pylori) is a common stomach infection affecting over 50% of the global population. This Nobel Prize-winning research explores H. pylori
Area of Science:
- Gastroenterology and Infectious Diseases
- Microbiology and Oncology
Background:
- Helicobacter pylori (H. pylori) is the most common bacterial infection worldwide, with over 50% of the global population infected.
- Despite the stomach's acidic environment, H. pylori can survive and cause persistent infections, first described in 1874 and isolated in 1982.
- The bacterium, renamed Helicobacter pylori in 1989, was recognized as a cause of gastric cancer, earning Warren and Marshall the Nobel Prize in 2005.
Purpose of the Study:
- To analyze the pros and cons of Helicobacter pylori infection.
- To define optimal treatment strategies and timing for H. pylori eradication.
- To identify patient groups requiring mandatory H. pylori eradication.
Main Methods:
- Review of epidemiological data on H. pylori prevalence.
- Analysis of H. pylori's pathogenic mechanisms and host response.
- Evaluation of scientific literature on H. pylori treatment and eradication protocols.
Main Results:
- H. pylori infection is widespread, often asymptomatic, but linked to gastric cancer.
- The bacterium's persistence is due to its adaptation to the gastric acid environment.
- Treatment efficacy and necessity vary based on strain, host factors, and clinical outcomes.
Conclusions:
- Understanding the dual nature of H. pylori (commensal vs. pathogen) is crucial.
- Timely and appropriate eradication is essential for preventing H. pylori-associated diseases, particularly gastric cancer.
- Further research is needed to refine treatment guidelines for specific patient populations.
Related Concept Videos
01:26Gastritis II: Pathophysiology
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
01:27Peptic Ulcer
Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
01:24Peptic Ulcer Disease II: Pathophysiology
Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
01:28Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
01:27Microbiota of the Stomach and Small Intestine
The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...